Helix BioPharma (TSX:HBP) 3-Year EBITDA Growth Rate : 21.00% (As of Jan. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma 3-Year EBITDA Growth Rate?

Helix BioPharma's EBITDA per Share for the three months ended in Jan. 2024 was C$-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 21.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 15.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Helix BioPharma was 25.90% per year. The lowest was -9.00% per year. And the median was 9.20% per year.

Competitive Comparison of Helix BioPharma's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Helix BioPharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helix BioPharma's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's 3-Year EBITDA Growth Rate falls into.

Helix BioPharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Helix BioPharma (TSX:HBP) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Helix BioPharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma (TSX:HBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

HBPCF:USA

Address

401 Bay Street, Suite 2704, Toronto, ON, CAN, M5H 2Y

Website

https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.